Joachim F. Wernicke

Chief Tech/Sci/R&D Officer at REPROS THERAPEUTICS INC

76 year

Health Technology

Consumer Services

Finance

Profile

Joachim F.
Wernicke is currently the Chief Medical Officer at Repros Therapeutics, Inc. He previously worked as the Vice President-Clinical & Regulatory Affairs at LivaNova USA, Inc. and as an Advisor at MediGen Group LLC.
He holds a doctorate degree from the University of California, Los Angeles and another doctorate degree from the University of California, Irvine.

Joachim F. Wernicke active positions

Companies	Position	Start
REPROS THERAPEUTICS INC	Chief Tech/Sci/R&D Officer	2013-02-04

All active positions of Joachim F. Wernicke

Former positions of Joachim F. Wernicke

Companies	Position	End
CYBERONICS, INC.	General Counsel	-
MediGen Group LLC MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas	Private Equity Investor	-

See the detail of Joachim F. Wernicke's experience

Training of Joachim F. Wernicke

University of California, Los Angeles	Doctorate Degree
University of California, Irvine	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joachim F. Wernicke's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
LivaNova USA, Inc. LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX.	Health Technology
Repros Therapeutics, Inc. Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX.	Health Technology
MediGen Group LLC MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas	Finance

See company connections

Stock Market
Insiders
Joachim F. Wernicke